AstraZeneca PLC is 167.6x more valuable than uniQure N.V. by market capitalization ($286.27 B vs $1.71 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | QURE | AZN |
|---|---|---|
| Market cap | $1.71 B | $286.27 B |
| US-listed rank | #2227 | #47 |
| Revenue (latest FY) | $16.10M | - |
| Net income (latest FY) | -$199.00M | - |
| Net margin | -1236.2% | - |
| SEC filings | 888 | 1,004 |
AstraZeneca PLC is 167.6x more valuable than uniQure N.V. by market capitalization ($286.27 B vs $1.71 B).
Full pages: uniQure N.V. and AstraZeneca PLC, or browse the full rankings.